Ansell stephen m (23 Ergebnisse)

Softcover. Zustand: Near Fine. Magazine. Printed wrappers. Octavo. 59pp. Buff wrappers. Bumped and faded spine, near fine. This issue features Roy Campbell, F.L. Lucas, and Jack Lindsay. Additional contributors include N.K. Cruickshank, Doreen Dunlop, Wrey Gardiner, A.H. Heys, Teresa Hooley, Esther Spencer, G.W. Harris, Sonia Bentzon, Freda C. Bond, Denis Turner, Stuart Holroyd, R.V. Blakemore, P.D. Cummins, Justin Richardson, Margaret Stanley-Wrench, Frank Lissauer, Sidonie Schall, Christopher Levenson, Michael Malim, Murrell Simmons, W.H. Hamilton, Laurence H. Williams, Dennis Peck, Valmai Richardson, Mary Banes, Kathleen M. Chapin, F.D. Walker, William Wolff, Alice Alment, S. Thomas Ansell, Peter Fison, Howard Parsons, Robert Greacen, Stephen Graham, John Graddon, Kennedy Williamson, Paul Selver, K.V. Richardson, and E. Royse Pritchard.…

Zustand: Good. 1st Edition. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 452 | Sprache: Englisch | Produktart: Bücher | Many comprehensive text books have been written about the common hematologic malignancies. However, every practicing hematologist/oncologist or primary care physician intermittently encounters patients with uncommon or rare hematologic malignancies. Information concerning these diseases, and particularly regarding their management, is extremely difficult to find. Physicians will commonly spend a substantial period of time searching the medical literature for help or will call a colleague who may have greater expertise in the area.Rare Hematological Malignancies covers malignant hematologic diseases that physicians would see only occasionally, providing accurate, up-to-date information on the disease biology and practical recommendations concerning the disease management.…

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Gebunden. Zustand: New. OWEN A. O CONNOR, MD, PhD, American Cancer Society Research Professor Professor of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA.STEPHEN M. ANSELL, MD, PhD, Consultant, Division of Hematology, Department of Internal Medicine, May.

Zustand: New. Owen A. O Connor, M.D., Ph.D. is an American Cancer Society Research Professor at the University of Virginia Comprehensive Cancer Center. He completed his training in Internal Medicine at the New York Presbyterian Hospital at Weill Cornell University Medica.

Zustand: New. In English.

Zustand: New. In English.

Zustand: Used. pp. 448.

Zustand: Used. pp. 448.

Hardcover. Zustand: Brand New. 496 pages. 10.98x8.66x1.30 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 482 pages. 10.75x8.25x1.25 inches. In Stock.

Zustand: New. 2023. 1st Edition. Hardcover. . . . . . Books ship from the US and Ireland.

Zustand: New. 2024. Volume 2. hardcover. . . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Neuware - Presents timely and authoritative information on the development of precision cancer therapies as applied to hematologic malignancies The Precision Cancer Therapies series focuses on how to understand and translate fundamental basic science into information that can be directly applied to patients to advance care. Each volume of the series integrates the relevant biological concepts and principles necessary for translating this science to practitioners of this science. Precision Cancer Therapies, Volume Two, focuses on sophisticated immunotherapies targeting cancers affecting the blood, bone marrow, and lymph nodes. Edited and authored by the foremost authorities in the field, this comprehensive reference text covers targeting of cell surface receptors, antibody-drug conjugates (ADC), targeting immune checkpoint, targeting macrophages, EBV-directed immunotherapies, tumor-associated antigens (TAA), and chimeric antigen receptor T-cells (CAR-T). Divided into nine sections, Volume Two includes an overview of the history of immunotherapy development in cancer, as well as a concluding section addressing the mechanistic basis and role of immunomodulatory drugs, analytical tools to quantitate immune-mediated effects, and other topics in immunotherapy. Chapters on specific therapeutics or therapeutic classes include a basic explanation of the underlying pathway and target, the pharmacology of the drug/class, relevant preclinical and clinical data, and discussion of clinical management and potential predictive biomarkers of response. This book also: - Delivers a definitive, state-of-the-art review of the relevant biology and its importance in the broader context of cancer biology - Focuses on agents that mediate cell killing in lymphoma through a variety of immunologic mechanisms - Covers FDA-approved drugs and their indications, as well as drugs currently in development - Provides information on monotherapy and combination therapy, summary tables of trials, and discussion of toxicity and efficacy - Includes boxed sections highlighting major unique points about the information in the chapter Precision Cancer Therapies, Volume Two: Immunologic Approaches for the Treatment of Lymphoid Malignancies, From Concept to Practice is an indispensable resource for medical, scientific, and allied medical professionals, advanced students, and interested general readers with background knowledge in the subject.…

Zustand: New. In English.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Many comprehensive text books have been written about the common hematologic malignancies. However, every practicing hematologist/oncologist or primary care physician intermittently encounters patients with uncommon or rare hematologic malignancies. Information concerning these diseases, and particularly regarding their management, is extremely difficult to find. Physicians will commonly spend a substantial period of time searching the medical literature for help or will call a colleague who may have greater expertise in the area.Rare Hematological Malignancies covers malignant hematologic diseases that physicians would see only occasionally, providing accurate, up-to-date information on the disease biology and practical recommendations concerning the disease management.…

Paperback. Zustand: Brand New. reprint edition. 443 pages. 9.00x6.00x1.05 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 432 pages. 9.25x6.25x1.25 inches. In Stock.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Many comprehensive text books have been written about the common hematologic malignancies. However, every practicing hematologist/oncologist or primary care physician intermittently encounters patients with uncommon or rare hematologic malignancies. Information concerning these diseases, and particularly regarding their management, is extremely difficult to find. Physicians will commonly spend a substantial period of time searching the medical literature for help or will call a colleague who may have greater expertise in the area.Rare Hematological Malignancies covers malignant hematologic diseases that physicians would see only occasionally, providing accurate, up-to-date information on the disease biology and practical recommendations concerning the disease management.…